NCT03533348 is a clinical trial in X-ray Contrast Media Adverse Reaction, sponsored by HaEmek Medical Center, Israel.

Who is sponsoring NCT03533348?

NCT03533348 is sponsored by HaEmek Medical Center, Israel.

What condition does NCT03533348 study?

NCT03533348 studies X-ray Contrast Media Adverse Reaction.

Is NCT03533348 still recruiting?

NCT03533348 is currently completed. Last updated 22 October 2019.

Last reviewed 2019-10-22 · How we verify

NCT03533348

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preparative Fasting Before Contrast-enhanced Computed Tomography

Completed Last updated 22 October 2019

What this trial tests

trial in X-ray Contrast Media Adverse Reaction in 2,148 participants. Completed in 10 October 2019.

Timeline

31 July 2018

Primary endpoint
10 October 2019

10 October 2019

Quick facts

Lead sponsor	HaEmek Medical Center, Israel
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,148
Start date	31 July 2018
Primary completion	10 October 2019
Estimated completion	10 October 2019
Sites	1 location across Israel

Conditions studied

X-ray Contrast Media Adverse Reaction — all drugs for X-ray Contrast Media Adverse Reaction →

Sponsor

HaEmek Medical Center, Israel

Who can join

18 and older, any sex, with X-ray Contrast Media Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to determine whether there is a need for preparative fasting prior to contrast-enhanced computed tomography (CT).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Is fasting still necessary prior to contrast-enhanced computed tomography? A randomized clinical study.
Neeman Z, Abu Ata M, Touma E, Saliba W, et al · · 2021 · cited 18× · PMID 32901302 · DOI 10.1007/s00330-020-07255-0
Preprocedural fasting for contrast-enhanced CT: when experience meets evidence.
Liu H, Liu Y, Zhao L, Li X, et al · · 2021 · cited 9× · PMID 34865183 · DOI 10.1186/s13244-021-01131-1

Verify or expand the search:

Other HaEmek Medical Center, Israel trials

Trials by the same sponsor.

NCT06656286 — Hysteroscopic Intrauterine Suturing · NA · not yet recruiting
NCT06803992 — Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter · Phase 4 · recruiting
NCT06542367 — Trans Canal Tympanoplasty With Local Anesthesia Using Fat Graft and "TachoSil" · NA · not yet recruiting
NCT05732155 — Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. · Phase 2 · unknown
NCT05933018 — Night Hyperglycemia and Fatty Liver in Type 1 Diabetes · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03533348 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by HaEmek Medical Center, Israel
Last refreshed: 22 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03533348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing